Can a Tumor's 'Neighborhood' predict drug success?

NCT ID NCT07584044

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study reviews medical records from 300 cancer patients to see if the makeup of a tumor's surroundings (the tumor microenvironment) is linked to how well antibody-based therapies work. Researchers will analyze tissue samples and blood markers from patients with seven types of cancer. The goal is to find patterns that could help personalize treatment, but no new drugs are being tested.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors predict which patients will benefit most from antibody-based cancer therapies, leading to more personalized treatment plans.
What could go wrong
This is a retrospective observational study, not a clinical trial testing a new treatment. It can show associations but cannot prove cause and effect. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIBODY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.